Bank Hapoalim Bm Abbott Laboratories Transaction History

Bank Hapoalim Bm

$707 Million
Q2 2024

A detailed history of Bank Hapoalim Bm transactions in Abbott Laboratories stock. As of the latest transaction made, Bank Hapoalim Bm holds 10,560 shares of ABT stock, worth $1.2 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

10,560

Previous 10,935 3.43%

Holding current value

$1.2 Million

Previous $1.24 Million 11.75%

% of portfolio

0.16%

Previous 0.16%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $37,773 - $42,165	-375 Reduced 3.43%	10,560 $1.1 Million
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $53,445 - $59,028	488 Added 4.67%	10,935 $1.24 Million
Q4 2023 Jan 22, 2024	BUY	$90.19 - $110.4 $942,214 - $1.15 Million	10,447 New	10,447 $1.15 Million
Q1 2023 Apr 25, 2023	BUY	$96.86 - $114.01 $77,681 - $91,436	802 Added 8.12%	10,682 $1.08 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $6,654 - $7,806	-70 Reduced 0.7%	9,880 $1.09 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $16,739 - $19,381	-173 Reduced 1.71%	9,950 $963,000
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $14,902 - $18,012	-146 Reduced 1.42%	10,123 $1.1 Million
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $84,374 - $102,889	-740 Reduced 6.72%	10,269 $1.22 Million
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $4,621 - $5,658	40 Added 0.36%	11,009 $1.55 Million
Q3 2021 Oct 27, 2021	SELL	$116.66 - $129.06 $2,099 - $2,323	-18 Reduced 0.16%	10,969 $1.3 Million
Q2 2021 Aug 05, 2021	BUY	$105.79 - $124.53 $205,549 - $241,961	1,943 Added 21.48%	10,987 $1.27 Million
Q1 2021 Apr 26, 2021	BUY	$108.84 - $128.23 $984,348 - $1.16 Million	9,044 New	9,044 $1.08 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $881,576 - $1.07 Million	-9,620 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$62.82 - $91.86 $604,328 - $883,693	9,620 New	9,620 $759,000
Q3 2019 Nov 01, 2019	SELL	$81.84 - $88.74 $870,777 - $944,193	-10,640 Closed	0 $0
Q1 2019 May 07, 2019	SELL	$66.22 - $80.06 $6,953 - $8,406	-105 Reduced 0.98%	10,640 $851,000
Q1 2018 Apr 30, 2018	BUY	$56.27 - $63.62 $5,908 - $6,680	105 Added 0.99%	10,745 $644,000
Q4 2017 Feb 05, 2018	BUY	$53.68 - $57.47 $118,096 - $126,434	2,200 Added 26.07%	10,640 $0
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $59,354 - $66,245	1,235 Added 17.14%	8,440 $450,000
Q2 2017 Aug 11, 2017	BUY	N/A	7,205	7,205 $350,000

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

News

Stay updated on Bank Hapoalim Bm with notifications on news.

Account